This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Products from multiple soldto's are in cart. Only products from single soldto is allowed in cart.
No Items In Cart
Deep-rooted in West’s culture, the health and safety of our team members has always been our top priority. And this remains consistent and strong despite the challenges brought on by COVID-19. Recently, our manufacturing plant in Sri City, India achieved 2,000 recordable incident free days, which is a tremendous milestone that demonstrates the team’s collaboration and commitment to safety at all levels of staff, from management to the plant floor.
The believe that “one incident is one too many” has been deeply reinforced at our Sri City site as well as all West locations.. Besides the effective implementation of a strong West HSE program and promotion of safety best practices, the Sri City team is committed to promoting positive safety culture proactively. The Safety Week annual event enjoys strong team members’ participation and engagement through various activities such as Safety Selfie, Safety Calendar, etc. In 2020, the team has gained a 100% participation rate for the 2020 Safety Perception Survey.
To celebrate the milestone, all the Sri City team members gathered together with AP regional leaders virtually. Stewart Campbell, VP & GM, AP, said: “I am extremely proud of the accomplishment for the Sri City plant and would like to thank every team member for your continuous focus and commitment on safety.” PT Tan, VP, Operations, AP, added: “It’s every team member’s attention to safety details and keeping a mindset of “See Something. Do Something. Say Something” that leads to such a great achievement. Keep going!”
“We encourage our team members to participate in safety sessions and events frequently,” shared Suresh Govindarajan, Director, Operations, Sri City, “It is the spirit of One West team that ensures all workers are looking out for one another and driving individual accountability. We strive to keep focus on safety as a tenet of our company culture.”
Congratulations to the entire team at Sri City and thank you for your continuous efforts on maintaining and improving safety! To learn more about our sites and locations across the globe, click here. If you are interested in learning more about our commitment on Health and Safety, click here for our newly-launched 2020 Corporate Responsibility Report.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.
Most cancer drugs are hazardous. OSHA, NIOSH and USP regulations, enacted to protect healthcare workers from exposure, stipulate the need for safe delivery. Needle-free devices, such as spikes, can help to meet this need. However, traditional spikes used in infusion systems have posed a concern with small drug vials — stopper push-in by spike incidents can occur.
West’s Kinston, NC facility was recently recognized with an Honorable Mention at the 2016 International Society for Pharmaceutical Engineering’s (ISPE) Facility of the Year Awards’ ceremony on June 7, 2016, in Bethesda, Maryland. The award acknowledged the West team’s creativity and innovation during the Ready-to-Sterilize (RS) Expansion project, which was completed in June 2015.
West’s location in Jurong, Singapore celebrated 40 years of operations and announced an inauguration of the newly advanced facility last month. This site’s updates will improve manufacturing efficiency for the future of containment for injectable medicines. Last month, Eric Green, CEO and President, customers, and other West executives attended the festivities and ribbon cutting.
<p style="margin: 0in 0in 10pt;"><span>When the first Generic Drug User Fee Act (GDUFA I) was enacted in 2012, The FDA’s Office of Generic drugs (OGD) was trying to manage a growing backlog of regulatory applications. The introduction of user fees to the generic drug approval process permitted FDA to increase resources to address the increasing review and inspection demands. In addition, GDUFA I set forth performance goals for the FDA over a 5-year span, resulting in reductions in both the generic drug application backlog and application review times. </span></p>
West works by the side of our health care partners to understand patient needs and provide integrated delivery systems that optimize the effectiveness of drug delivery while enhancing the patient experience. Creative business models will ensure effective collaboration, either by leveraging West’s proprietary technologies or partnering with individual customers through the development process to apply West’s design, engineering and manufacturing skills to create customer-specific solutions.